FDA Import Refusal 799-5996076-5/21/2 — Sciegen Pharmaceuticals Inc
The FDA refused shipment 799-5996076-5/21/2 from Sciegen Pharmaceuticals Inc (United States) on Nov 26, 2021. The refused product falls under Drugs and Biologics — GABAPENTIN (ANTI-DEPRESSANT). Cited charge: 72 This firm has 2 other import refusals on record.
Refusal Details
- Date
- Nov 26, 2021
- Country
- United States
- Product Category
- Drugs and Biologics
- Product Code
- 61NQA69 GABAPENTIN (ANTI-DEPRESSANT)
- Charges
- 72